Second phase III trial of forigerimod for systemic lupus erythematosus.
Phase of Trial: Phase III
Latest Information Update: 30 Apr 2015
Price : $35 *
At a glance
- Drugs Forigerimod (Primary)
- Indications Systemic lupus erythematosus
- Focus Registrational; Therapeutic Use
- 30 Apr 2015 According to ImmuPharma media release, agreement was signed with Simbec-Orion an international clinical research organisation to under take crucial Phase III clinical trial.
- 13 Aug 2013 New trial record
- 12 Aug 2013 This is one of two trials in the phase III programme, according to an ImmuPharma media release.